Rabeprazole sodium (PARIET®) tablets are indicated for the treatment of:

  • Active duodenal ulcer
  • Active benign gastric ulcer
  • Anastomotic ulcer
  • Erosive or ulcerative gastro-esophageal reflux disease (GERD)
  • Gastro-esophageal reflux disease long-term management (GERD maintenance)
  • Symptomatic treatment of moderate lo very severe gastro-esophageal reflux disease (symptomatic GERD)
  • Zollinger-Ellison Syndrome and other pathological hypersecretory conditions
  • Prevention of gastric and duodenal ulcer recurrences associated with low-dose aspirin therapy
  • In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease.